Explore the complete record of transactions filed by Wood Gavin, 首席财务官. Insider active across 1 company, notably Adaptimmune Therapeutics PLC. Cumulatively, 1 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €11k. Activity tracked since 20 May 2022. The latest transaction was filed on 20 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Wood Gavin is the Chief Financial Officer at Adaptimmune Therapeutics PLC. He is responsible for the financial management of the company, including financial planning and reporting. His expertise is essential to support the company's growth and profitability.